Congenital and acquired lipodystrophy share a common pathophysiology: adipose tissue dysfunction, an alteration that results in most cases in hypertriglyceridemia, ectopic fat accumulation, insulin resistance, chronic inflammation and low levels of leptin and adiponectin. The gene discussed is ADIPOQ; the disease is hypertriglyceridemia.